Yahoo Web Search

  1. Investors in Allergan plc AGN need to pay close attention to the stock based on moves in the options market lately. Options with high levels of implied volatility suggest that ...

  2. Can Value Investors Consider Allergan (AGN) a Worthy Pick?

    Zacks via Yahoo FinanceAug 13 13:45 PM

    Value investing is easily one of the most popular ways to find great stocks in any market environment. One way to find these companies is by looking at several key metrics and financial ratios ...

  3. Shares of Amgen Inc. AMGN have risen 22.6% in the past three months against a 0.9% decrease registered by the industry during this period. The district court’s decision last Friday, upholding ...

  4. Evolus Inc on Monday reported revenue of $2.3 million from early sales of its newly launched rival to Allergan Plc's Botox, ahead of its own expectations. Jeuveau, a neurotoxin ...

  5. Medical aesthetics company Evolus Inc on Monday beat Wall Street estimates for second-quarter revenue from its newly launched rival to Allergan Plc's Botox, which has dominated ...

  6. The latest round of 13F filings from institutional investors were out this week, revealing to the world the stocks that some of the richest and most successful investors have been buying and ...

  7. Humira brought in global revenue of $4.87 billion in the second quarter, but sales have been hit by competition from cheaper rivals in Europe, and AbbVie in June announced a deal to buy Botox-maker ...

  8. Argentina Apoplexy, IPOs and Other Things to Watch on 13F Day

    Bloomberg via Yahoo FinanceAug 13 21:58 PM

    Managers including Autonomy Capital’s Robert Gibbins and Pointstate Capital’s Zach Schreiber started the year with bets on Argentine companies that trade in the U.S. After hedge funds finish ...

  1. Ads
    related to ALLERGAN PLC